{
  "id": "fda_guidance_chunk_0721",
  "title": "Introduction - Part 721",
  "text": "use of the analytical method for the intended measurements. 8.6.4 Certification that all needed validations will be done before the initiation of the study 8.7 Study Facilities: 8.7.1 Containment equipment (cages, pens, runs, stalls, etc.) 8.7.2 Lighting equipment (if controlled define photo period) 8.7.3 Heating equipment 8.7.4 Cooling equipment 8.7.5 Feeding equipment 8.7.6 Watering equipment 8.7.7 Ventilation equipment 8.7.8 Space allocation per animal (compare to normal management practices) 8.7.9 Pasture description (area, forage, rotation, etc.) 8.7.10 Facility diagram: 8.7.10.1 Location of feeding and watering equipment 8.7.10.2 Orientation of building 8.7.10.3 Ventilation 8.7.10.4 Location of lighting 8.7.10.5 Pen/cage dimensions 8.7.10.6 Orientation of blocks 8.7.10.7 Treatment code 8.7.10.8 Environmental/weather recording devices 8.8 Experimental Diet(s) (if applicable): 8.8.1 Diet formulation(s): 8.8.1.1 Ingredient list: 8.8.1.1.1 Feedstuffs 8.8.1.1.2 Vitamin premixes 8.8.1.1.3 Mineral premixes 8.8.1.1.4 Feed additives (drugs, antioxidants, pellet binders, copper sulfate, etc.) 8.8.2 Nutrient and drug concentration of experimental diet(s): (Define feed sampling procedure) 8.8.2.1 Calculated nutrient concentration 8.8.2.2 Assayed nutrient concentration 8.8.2.2.1 Assay procedure 8.8.2.2.2 Analytical laboratory: 8.8.2.2.2.1 Address 8.8.2.2.2.2 Telephone number 8.8.2.3 Assayed drug concentration: 8.8.2.3.1 Specify drug(s) that will be assayed in each treatment group for each type of diet 8.8.2.3.2 Anticipated analytical variation and assay limits 8.8.2.3.3 Analytical method 8.8.2.3.4 Analytical laboratory: 8.8.2.3.4.1 Address 8.8.2.3.4.2 Telephone number 8.8.2.3.5 Number of assay replicates 8.8.3 Feed form, (i.e. mash, crumbled, pellets) 8.8.4 Manufacture of experimental diet(s): 8.8.4.1 Procedures 8.8.4.2 Facilities and equipment 8.8.5 Feeding program, (i.e. schedule for feeding experimental diets) 8.8.6 Watering program 8.9 Drug Administration: 8.9.1 Dosing regime (dose(s), frequency, and duration) 8.9.2 Route of administration 8.9.3 Investigational withdrawal period (reference the appropriate CVM authorization letter) 8.9.4 Proposed withdrawal period (anticipated labeled withdrawal period) 8.10 Removal of Subject(s) from the study: 8.10.1 Criteria for removal of subjects from the study 8.10.2 Procedures for removal of subjects from the study 8.10.3 Fate of removed study animals 8.11 Concurrent/Concomitant Medications/Therapies 8.12 General management practices, e.g. frequency of visits to facility site, frequency of checking feeders and waterers, frequency of adding feed to feeders, frequency of checking for temperature and humidity, distribution of used litter across treatment groups, used or new litter, etc. 8.13 Provisions for necropsy and disposal of expired test subjects 8.14 Owner Consent (if applicable) 9 SPECIFICATION OF VARIABLES: 9.1 Variable(s) to be measured for evaluating labeled claim: 9.1.1 When variable(s) will be assessed",
  "source": "FDA_clinical_trial_guidance.txt",
  "section_heading": "Introduction",
  "start_pos": 967680,
  "end_pos": 969216,
  "tokens": 512,
  "tags": [
    "clinical_trial",
    "consent"
  ],
  "jurisdiction": "US",
  "document_type": "fda_guidance",
  "guidance_section": "general_guidance",
  "regulatory_weight": "guidance",
  "created_at": "2025-10-23T02:25:44.733Z"
}